Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • AthenaHQ Reviews & Ratings
    3 Ratings
    Company Website
  • Stack AI Reviews & Ratings
    16 Ratings
    Company Website
  • PESTBOSS Reviews & Ratings
    2 Ratings
    Company Website
  • wp2print Reviews & Ratings
    23 Ratings
    Company Website
  • Testsigma Reviews & Ratings
    65 Ratings
    Company Website
  • Megaventory Reviews & Ratings
    158 Ratings
    Company Website
  • Semrush Reviews & Ratings
    5,668 Ratings
    Company Website
  • Epicor Vision Reviews & Ratings
    7 Ratings
    Company Website
  • Pipedrive Reviews & Ratings
    8,428 Ratings
    Company Website
  • SDS Manager Reviews & Ratings
    2 Ratings
    Company Website

What is Iktos?

Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.

What is Bruker Drug Discovery?

The journey of bringing a new drug to market involves a complex, time-consuming, and expensive process that is subject to stringent regulations, often taking more than ten years to complete. The success of this venture largely depends on the early acquisition of accurate analytical data, which is essential for making informed choices during the early phases of development and for minimizing the chances of failures in later stages. Typically, the modern drug development process adheres to a systematic approach, starting with the identification of a biological target that becomes the centerpiece of the research efforts. This foundational step requires a deep understanding of the properties of potential candidates to efficiently and effectively identify the most promising options. Once the biological target is identified, the subsequent challenge is to find the most advantageous lead molecules, which includes discovering potential drug candidates that may consist of small organic compounds or biologic entities that show therapeutic potential. Additionally, this entire process highlights the necessity for cross-disciplinary collaboration and innovative thinking, emphasizing the intricate nature of converting a scientific concept into an effective medication. Ultimately, the path from idea to treatment is not just about scientific discovery but also about navigating the complexities of regulatory landscapes and market dynamics.

Media

Media

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

Integrations Supported

Amazon Web Services (AWS)
Google Cloud Platform
Microsoft Azure
Python

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Iktos

Company Location

France

Company Website

iktos.ai/makya/

Company Facts

Organization Name

Bruker

Date Founded

1960

Company Location

United States

Company Website

www.bruker.com/en/applications/pharma/drug-discovery.html

Categories and Features

Categories and Features

Popular Alternatives

SILCS Reviews & Ratings

SILCS

SilcsBio

Popular Alternatives

BIOVIA Discovery Studio Reviews & Ratings

BIOVIA Discovery Studio

Dassault Systèmes
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA
BIOiSIM Reviews & Ratings

BIOiSIM

VERISIMLife
SILCS Reviews & Ratings

SILCS

SilcsBio